GABRA1 and juvenile myoclonic epilepsy: In a study including fifteen children with a variant of the GABRA1 gene, seven were treated with ASMs and remained seizure free, including two patients with juvenile myoclonic epilepsy and one patient with GEFS+ treated with VAP monotherapy.